NCT07868588 Leveraging Interventions for Caregiver Growth, Health, Training, Empowerment and Navigation: Comparing Group Behavioral Interventions to Improve Dementia Caregiver Strain
| NCT ID | NCT07868588 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Elevated Caregiver Strain |
| Study Type | INTERVENTIONAL |
| Enrollment | 450 participants |
| Start Date | 2026-10-13 |
| Primary Completion | 2031-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 450 participants in total. It began in 2026-10-13 with a primary completion date of 2031-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare two group-based interventions for caregivers of persons with memory loss (N=450) delivered via telehealth. The aim is to evaluate which program is most effective for different types of caregivers in reducing stress, improving coping, and increasing confidence related to caregiving. Participants will be randomly assigned to one of the two programs, as well as be asked to complete study assessments at baseline (week 0), post-intervention (week 7), and 6-month follow-up.
Eligibility Criteria
While the below criteria reference both the caregiver and care recipient, only caregivers will be enrolled in this study. Inclusion Criteria: * Caregiver of a person with memory loss currently * Care recipient currently living in community * Caregiver at least 18 years of age * Caregiver Zarit Burden Interview-6 (ZBI-6) greater than or equal to 9 or ZBI-22 greater than or equal to 34 * English or Spanish fluency/literacy * Able and willing to participate Exclusion Criteria: * Care recipient enrolled or planning to enroll in hospice * Severe, untreated mental illness or substance use (self or clinician report) * Active suicide risk * Residence outside the U.S. during study procedures
Contact & Investigator
Evan Plys, PhD
PRINCIPAL INVESTIGATOR
Massachusetts General Hospital
Frequently Asked Questions
Who can join the NCT07868588 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Elevated Caregiver Strain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07868588 currently recruiting?
Yes, NCT07868588 is actively recruiting participants. Contact the research team at mghlightenstudy@mgb.org for enrollment information.
Where is the NCT07868588 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07868588 clinical trial?
NCT07868588 is sponsored by Massachusetts General Hospital. The principal investigator is Evan Plys, PhD at Massachusetts General Hospital. The trial plans to enroll 450 participants.